Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
06/08/2000 | WO2000032307A1 Preparation of multiwall polymeric microcapsules from hydrophilic polymers |
06/08/2000 | WO2000032256A1 Blood pump without bearing |
06/08/2000 | WO2000032255A1 Polymeric coatings with controlled delivery of active agents |
06/08/2000 | WO2000032234A1 Topical compositions comprising ascomycins |
06/08/2000 | WO2000032233A2 Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith |
06/08/2000 | WO2000032230A1 Immunoglobulin preparations |
06/08/2000 | WO2000032224A2 Calcitonin for the modulation of sperm function |
06/08/2000 | WO2000032220A1 Anti-dandruff composition comprising an antifungal polypeptide |
06/08/2000 | WO2000032219A1 A pharmaceutical composition comprising cyclosporin in a lipid carrier |
06/08/2000 | WO2000032218A1 Controlled release formulation comprising gnrh-ii |
06/08/2000 | WO2000032207A1 Spray delivery of cells |
06/08/2000 | WO2000032191A1 New pharmaceutical composition and the process for its preparation |
06/08/2000 | WO2000032189A1 Celecoxib compositions |
06/08/2000 | WO2000032186A2 Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents |
06/08/2000 | WO2000032184A1 Skin preparations for external use |
06/08/2000 | WO2000032179A2 Use of nicotonic acid derivatives for the treatment of dna damage in skin cells |
06/08/2000 | WO2000032174A2 Pharmaceutical combination preparations of carvedilol and hydrochlorothiazide |
06/08/2000 | WO2000032173A1 Improved dissolution of triprolidine hydrochloride |
06/08/2000 | WO2000032172A1 An oral formulation for gastrointestinal drug delivery |
06/08/2000 | WO2000032171A2 Autoahesive oral transmucosal delivery dosage form |
06/08/2000 | WO2000032170A1 Preparation of dry compositions soluble in the presence of water and avoiding maillard reaction in dry state and uses |
06/08/2000 | WO2000032169A2 Method for producing solid forms of administration by melt extrusion |
06/08/2000 | WO2000032168A1 Utilisation of capsules containing one or more antigenic substances for the prevention and/or treatment of autoimmune diseases |
06/08/2000 | WO2000032167A1 A polysome |
06/08/2000 | WO2000032166A2 Microparticles containing water insoluble active agents |
06/08/2000 | WO2000032165A1 Milling process for the production of finely milled medicinal substances |
06/08/2000 | WO2000016752A3 Transdermal devices comprising essential oils for aromatherapy |
06/08/2000 | WO2000015245A3 Stable liquid formulations of botulinum toxin |
06/08/2000 | WO2000010533A3 Compositions and methods for treating intracellular infections |
06/08/2000 | WO2000009652A3 Method for the preparation of oxide microcapsules loaded with functional molecules and the products obtained thereof |
06/08/2000 | WO2000009086A3 Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods |
06/08/2000 | WO1999065452B1 Hydrogels of water soluble polymers crosslinked by protein domains |
06/08/2000 | WO1999011232A8 Oral compositions |
06/08/2000 | DE19959689A1 Liposome composition for tumor, especially breast cancer, therapy comprises an alkyl phospholipid with antineoplastic activity and one or more antiestrogens |
06/08/2000 | DE19856147A1 Teilbare feste Dosierungsformen und Verfahren zu ihrer Herstellung Divisible solid dosage forms and methods for their preparation |
06/08/2000 | DE19856101A1 Patch for local administration of drugs in the oral cavity includes a drug-containing matrix comprising a water-insoluble cellulose ether and a water-soluble cellulose ether in a defined ratio |
06/08/2000 | DE19855440A1 Verfahren zum Herstellen fester Darreichungsformen mittels Schmelzextrusion A method for producing solid dosage forms by melt extrusion |
06/08/2000 | CA2354187A1 Calcitonin for the modulation of sperm function |
06/08/2000 | CA2353798A1 Controlled release formulation comprising gnrh-ii |
06/08/2000 | CA2352874A1 Method for producing solid forms of administration by melt extrusion |
06/08/2000 | CA2352810A1 Spray delivery of cells |
06/08/2000 | CA2352779A1 Milling process for the production of finely milled medicinal substances |
06/08/2000 | CA2352749A1 Anti-dandruff composition comprising an antifungal polypeptide |
06/08/2000 | CA2352487A1 Utilisation of capsules containing one or more antigenic substances for the prevention and/or treatment of autoimmune diseases |
06/08/2000 | CA2352388A1 A pharmaceutical composition comprising cyclosporin in a lipid carrier |
06/08/2000 | CA2352321A1 Derivatives of (+)-venlafaxine and methods of preparing and using the same |
06/08/2000 | CA2350635A1 Therapeutic product and its use |
06/08/2000 | CA2349483A1 Blood pump without bearing |
06/07/2000 | EP1006148A1 Coprocessed polysaccharide product |
06/07/2000 | EP1006126A2 Osteogenic peptides |
06/07/2000 | EP1005864A1 Antioxidant free stable pharmaceutical compositions containing thienopyridine derivatives |
06/07/2000 | EP1005863A1 Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof |
06/07/2000 | EP1005860A1 Non-chlorofluorocarbon aerosol formulations |
06/07/2000 | EP1005859A1 Method for producing dispersible sterol and stanol compounds |
06/07/2000 | EP1005857A1 O/w-emulsions with a high wax content and their use in the cosmetic and dermatologic fields |
06/07/2000 | EP1005851A1 Cosmetic or dermatological composition comprising at least one alkynyl carbamate and at least one polyol |
06/07/2000 | EP1005490A1 Zinc free insulin crystals for use in pulmonary compositions |
06/07/2000 | EP1005485A1 Novel pulmonary surfactants and therapeutic uses, including pulmonary lavage |
06/07/2000 | EP1005466A1 Tetraether lipid derivatives and liposomes and lipid agglomerates containing tetraetherlipid derivatives, and use thereof |
06/07/2000 | EP1005391A1 Process for preparation of vesicles |
06/07/2000 | EP1005374A1 Microparticles for delivery of nucleic acid |
06/07/2000 | EP1005367A2 Vaccines containing bordetella pertussis antigen |
06/07/2000 | EP1005364A1 Method of protecting against chronic infections |
06/07/2000 | EP1005351A1 An aqueous metal bicarbonate solution and method of use |
06/07/2000 | EP1005346A2 Solutions containing azasteroids |
06/07/2000 | EP1005339A1 Carotenoid formulation |
06/07/2000 | EP1005336A1 Improved methods and compositions for treating male erectile dysfunction |
06/07/2000 | EP1005335A1 Process for preparing a reactive pharmaceutical product for the detection of gastrointestinal disorder caused by bacteria in the gastrointestinal superior tract |
06/07/2000 | EP1005329A1 Rapidly disintegrating methylcellulose tablets |
06/07/2000 | EP1005328A1 Composition comprising finely divided, crystalline particles of budesonide |
06/07/2000 | EP1005327A1 Targeted liposomal constructs for diagnostic and therapeutic uses |
06/07/2000 | EP1005326A1 Method for producing liposomes with increased percent of compound encapsulated |
06/07/2000 | EP1005324A1 Compositions for delivery of biological agents and methods for the preparation thereof |
06/07/2000 | EP0983061A4 Methods for administering nutritional indium |
06/07/2000 | EP0773025B1 New stable galenic formulations containing an acid-labile benzimidazol compound, and production process |
06/07/2000 | EP0714304B1 Therapeutic system for treating psoriasis |
06/07/2000 | CN1255877A Method for producing small-particle prepns. of biologically active substances |
06/07/2000 | CN1255863A Green porphyrins as immunomodulators |
06/07/2000 | CN1255852A Novel method and compsns. for drug feeding of taxad alkyl compounds |
06/07/2000 | CN1255851A Multiparticulate pharmaceutical form, particles constituting it, method and plant for making same |
06/07/2000 | CN1255850A Topical compsns. |
06/07/2000 | CN1255849A Medical compsns. |
06/07/2000 | CN1255848A Process for making flurbiprofen lozenges |
06/07/2000 | CN1255847A Cosmetics |
06/07/2000 | CN1255829A Stable ascorbic acid inorganic salt liquid compsns., its prepn. method and applications |
06/07/2000 | CN1255373A Medicine for treating multiple skin diseases and its preparing process |
06/07/2000 | CN1255364A Antalgic spray and its preparing process |
06/07/2000 | CN1255354A Process for preparing injection to treat pulmonary tuberculosis |
06/07/2000 | CN1255352A Ointment for treating acne |
06/07/2000 | CN1255351A Decrustation ointment for burn and its preparing process |
06/07/2000 | CN1255347A Honeysuckle flower injection and its preparing process |
06/07/2000 | CN1255339A Chinese-medicinal instant particles for promoting milk secretion and recovery of puerperant |
06/07/2000 | CN1255338A Medicine for treating anorexia |
06/07/2000 | CN1255337A Medicine for treating hydrocephalus |
06/07/2000 | CN1255336A Medicine for treating apoplexy and thrombus |
06/07/2000 | CN1255335A Cathartic |
06/07/2000 | CN1255334A Ointment for treating face mite disease |
06/07/2000 | CN1255332A Release-controlled micropill for treating benign prostatic hyperplasis and its preparing process |
06/07/2000 | CN1255331A Hollow prosomatic liposome, its preparing process and clinical application of its encapsulated matter |
06/07/2000 | CN1053117C Processes for prepn. of compsns. used in treatment of kaposi |